T1	AdverseReaction 158 164	asthma
T2	AdverseReaction 173 178	death
T3	Factor 150 154	risk
T4	AdverseReaction 425 430	cough
T5	AdverseReaction 432 450	oropharyngeal pain
T6	AdverseReaction 452 467	nasopharyngitis
T7	AdverseReaction 469 477	headache
T8	AdverseReaction 482 488	nausea
T9	AdverseReaction 2137 2141	COPD
T10	AdverseReaction 2146 2153	dyspnea
T11	AdverseReaction 2206 2223	COPD exacerbation
T12	AdverseReaction 2225 2234	pneumonia
T13	AdverseReaction 2236 2251	angina pectoris
T14	AdverseReaction 2257 2276	atrial fibrillation
T15	AdverseReaction 3091 3096	Cough
T16	AdverseReaction 3145 3163	Oropharyngeal pain
T17	AdverseReaction 3236 3251	Nasopharyngitis
T18	AdverseReaction 3321 3329	Headache
T19	AdverseReaction 3406 3412	Nausea
T20	AdverseReaction 4016 4028	muscle spasm
T21	AdverseReaction 4030 4050	musculoskeletal pain
T22	AdverseReaction 4112 4128	edema peripheral
T23	AdverseReaction 4169 4186	diabetes mellitus
T24	AdverseReaction 4188 4201	hyperglycemia
T25	AdverseReaction 4236 4245	sinusitis
T26	AdverseReaction 4247 4280	upper respiratory tract infection
T28	AdverseReaction 4475 4480	cough
T29	AdverseReaction 4629 4634	cough
T30	AdverseReaction 4731 4736	Cough
T31	AdverseReaction 5489 5508	asthma exacerbation
T32	AdverseReaction 5294 5300	deaths
T34	AdverseReaction 6349 6375	hypersensitivity reactions
T35	AdverseReaction 6377 6401	paradoxical bronchospasm
T36	AdverseReaction 6403 6414	tachycardia
T37	AdverseReaction 6415 6434	heart rate increase
T38	AdverseReaction 6435 6447	palpitations
T39	AdverseReaction 6449 6457	pruritus
T40	AdverseReaction 6458 6462	rash
T41	AdverseReaction 6467 6476	dizziness
T42	AdverseReaction 3511 3543	cardiovascular adverse reactions
T43	Negation 4781 4784	not
T44	AdverseReaction 4801 4813	bronchospasm
T45	AdverseReaction 4815 4828;705 742	exacerbations Chronic Obstructive Pulmonary Disease
T46	AdverseReaction 4830 4855;705 742	deteriorations of disease Chronic Obstructive Pulmonary Disease
T47	AdverseReaction 4859 4875	loss of efficacy
T48	Negation 5356 5358	no
T49	AdverseReaction 5359 5365	deaths
T33	AdverseReaction 5819 5825	deaths
T50	Negation 5816 5818	No
T52	AdverseReaction 5880 5899	asthma exacerbation
E1	AdverseReaction:T1 Hypothetical:E3
E2	AdverseReaction:T2 Hypothetical:E3
E3	Factor:T3
E4	AdverseReaction:T4
E5	AdverseReaction:T5
E6	AdverseReaction:T6
E7	AdverseReaction:T7
E8	AdverseReaction:T8
E9	AdverseReaction:T9
E10	AdverseReaction:T10
E11	AdverseReaction:T11
E12	AdverseReaction:T12
E13	AdverseReaction:T13
E14	AdverseReaction:T14
E15	AdverseReaction:T15
E16	AdverseReaction:T16
E17	AdverseReaction:T17
E18	AdverseReaction:T18
E19	AdverseReaction:T19
E20	AdverseReaction:T20
E21	AdverseReaction:T21
E22	AdverseReaction:T22
E23	AdverseReaction:T23
E24	AdverseReaction:T24
E25	AdverseReaction:T25
E26	AdverseReaction:T26
E28	AdverseReaction:T28
E29	AdverseReaction:T29
E30	AdverseReaction:T30
E31	AdverseReaction:T31
E32	AdverseReaction:T32
E34	AdverseReaction:T34
E35	AdverseReaction:T35
E36	AdverseReaction:T36
E37	AdverseReaction:T37
E38	AdverseReaction:T38
E39	AdverseReaction:T39
E40	AdverseReaction:T40
E41	AdverseReaction:T41
E42	AdverseReaction:T42
E43	Negation:T43
E44	AdverseReaction:T44 Negated:E43
E45	AdverseReaction:T45 Negated:E43
E46	AdverseReaction:T46 Negated:E43
E47	AdverseReaction:T47 Negated:E43
E48	Negation:T48
E49	AdverseReaction:T49 Negated:E48
E33	AdverseReaction:T33 Negated:E50
E50	Negation:T50
E52	AdverseReaction:T52
A1	CUI E1 C0004096
A2	UMLS-Preferred-Name E1 Asthma
A3	MEDDRA-PT E1 Asthma
A4	MEDDRA-PT-ID E1 10003553
A5	CUI E2 C1306577
A6	UMLS-Preferred-Name E2 Death (finding)
A7	MEDDRA-PT E2 Death
A8	MEDDRA-PT-ID E2 10011906
A9	CUI E4 C0010200
A10	UMLS-Preferred-Name E4 Coughing
A11	MEDDRA-PT E4 Cough
A12	MEDDRA-PT-ID E4 10011224
A13	CUI E5 C2363731
A14	UMLS-Preferred-Name E5 Oropharyngeal pain
A15	MEDDRA-PT E5 Oropharyngeal pain
A16	MEDDRA-PT-ID E5 10068319
A17	CUI E6 C0027441
A18	UMLS-Preferred-Name E6 Nasopharyngitis
A19	MEDDRA-PT E6 Nasopharyngitis
A20	MEDDRA-PT-ID E6 10028810
A21	CUI E7 C0018681
A22	UMLS-Preferred-Name E7 Headache
A23	MEDDRA-PT E7 Headache
A24	MEDDRA-PT-ID E7 10019211
A25	CUI E8 C0027497
A26	UMLS-Preferred-Name E8 Nausea
A27	MEDDRA-PT E8 Nausea
A28	MEDDRA-PT-ID E8 10028813
A29	CUI E9 C0024117
A30	UMLS-Preferred-Name E9 Chronic Obstructive Airway Disease
A31	MEDDRA-PT E9 Chronic obstructive pulmonary disease
A32	MEDDRA-PT-ID E9 10009033
A33	LLT E9 COPD
A34	LLT-ID E9 10010952
A35	CUI E10 C0013404
A36	UMLS-Preferred-Name E10 Dyspnea
A37	MEDDRA-PT E10 Dyspnoea
A38	MEDDRA-PT-ID E10 10013968
A39	LLT E10 Dyspnea
A40	LLT-ID E10 10013963
A41	CUI E11 C0740304
A42	UMLS-Preferred-Name E11 COPD exacerbation
A43	MEDDRA-PT E11 Chronic obstructive pulmonary disease
A44	MEDDRA-PT-ID E11 10009033
A45	LLT E11 COPD exacerbation
A46	LLT-ID E11 10010953
A47	CUI E12 C0032285
A48	UMLS-Preferred-Name E12 Pneumonia
A49	MEDDRA-PT E12 Pneumonia
A50	MEDDRA-PT-ID E12 10035664
A51	CUI E13 C0002962
A52	UMLS-Preferred-Name E13 Angina Pectoris
A53	MEDDRA-PT E13 Angina pectoris
A54	MEDDRA-PT-ID E13 10002383
A55	CUI E14 C0004238
A56	UMLS-Preferred-Name E14 Atrial Fibrillation
A57	MEDDRA-PT E14 Atrial fibrillation
A58	MEDDRA-PT-ID E14 10003658
A59	CUI E15 C0010200
A60	UMLS-Preferred-Name E15 Coughing
A61	MEDDRA-PT E15 Cough
A62	MEDDRA-PT-ID E15 10011224
A63	CUI E16 C2363731
A64	UMLS-Preferred-Name E16 Oropharyngeal pain
A65	MEDDRA-PT E16 Oropharyngeal pain
A66	MEDDRA-PT-ID E16 10068319
A67	CUI E17 C0027441
A68	UMLS-Preferred-Name E17 Nasopharyngitis
A69	MEDDRA-PT E17 Nasopharyngitis
A70	MEDDRA-PT-ID E17 10028810
A71	CUI E18 C0018681
A72	UMLS-Preferred-Name E18 Headache
A73	MEDDRA-PT E18 Headache
A74	MEDDRA-PT-ID E18 10019211
A75	CUI E19 C0027497
A76	UMLS-Preferred-Name E19 Nausea
A77	MEDDRA-PT E19 Nausea
A78	MEDDRA-PT-ID E19 10028813
A79	CUI E20 C0037763
A80	UMLS-Preferred-Name E20 Spasm
A81	MEDDRA-PT E20 Muscle spasms
A82	MEDDRA-PT-ID E20 10028334
A83	LLT E20 Muscle spasm
A84	LLT-ID E20 10028333
A85	CUI E21 C0026858
A86	UMLS-Preferred-Name E21 Musculoskeletal Pain
A87	MEDDRA-PT E21 Musculoskeletal pain
A88	MEDDRA-PT-ID E21 10028391
A89	CUI E22 C0085649
A90	UMLS-Preferred-Name E22 Peripheral edema
A91	MEDDRA-PT E22 Oedema peripheral
A92	MEDDRA-PT-ID E22 10030124
A93	LLT E22 Edema peripheral
A94	LLT-ID E22 10014251
A95	CUI E23 C0011849
A96	UMLS-Preferred-Name E23 Diabetes Mellitus
A97	MEDDRA-PT E23 Diabetes mellitus
A98	MEDDRA-PT-ID E23 10012601
A99	CUI E24 C0020456
A100	UMLS-Preferred-Name E24 Hyperglycemia
A101	MEDDRA-PT E24 Hyperglycaemia
A102	MEDDRA-PT-ID E24 10020635
A103	LLT E24 Hyperglycemia
A104	LLT-ID E24 10020639
A105	CUI E25 C0037199
A106	UMLS-Preferred-Name E25 Sinusitis
A107	MEDDRA-PT E25 Sinusitis
A108	MEDDRA-PT-ID E25 10040753
A109	CUI E26 C0041912
A110	UMLS-Preferred-Name E26 Upper Respiratory Infections
A111	MEDDRA-PT E26 Upper respiratory tract infection
A112	MEDDRA-PT-ID E26 10046306
A113	CUI E28 C0010200
A114	UMLS-Preferred-Name E28 Coughing
A115	MEDDRA-PT E28 Cough
A116	MEDDRA-PT-ID E28 10011224
A117	CUI E29 C0010200
A118	UMLS-Preferred-Name E29 Coughing
A119	MEDDRA-PT E29 Cough
A120	MEDDRA-PT-ID E29 10011224
A121	CUI E30 C0010200
A122	UMLS-Preferred-Name E30 Coughing
A123	MEDDRA-PT E30 Cough
A124	MEDDRA-PT-ID E30 10011224
A125	CUI E31 C0349790
A126	UMLS-Preferred-Name E31 Exacerbation of asthma
A127	MEDDRA-PT E31 Asthma
A128	MEDDRA-PT-ID E31 10003553
A129	LLT E31 Exacerbation of asthma
A130	LLT-ID E31 10015575
A131	CUI E32 C1306577
A132	UMLS-Preferred-Name E32 Death (finding)
A133	MEDDRA-PT E32 Death
A134	MEDDRA-PT-ID E32 10011906
A135	CUI E34 C0020517
A136	UMLS-Preferred-Name E34 Hypersensitivity
A137	MEDDRA-PT E34 Hypersensitivity
A138	MEDDRA-PT-ID E34 10020751
A139	LLT E34 Hypersensitivity reaction
A140	LLT-ID E34 10020756
A141	CUI E35 C0236072
A142	UMLS-Preferred-Name E35 Paradoxical bronchospasm
A143	MEDDRA-PT E35 Bronchospasm paradoxical
A144	MEDDRA-PT-ID E35 10006486
A145	LLT E35 Paradoxical bronchospasm
A146	LLT-ID E35 10033770
A147	CUI E36 C0039231
A148	UMLS-Preferred-Name E36 Tachycardia
A149	MEDDRA-PT E36 Tachycardia
A150	MEDDRA-PT-ID E36 10043071
A151	CUI E37 C0039231
A152	UMLS-Preferred-Name E37 Tachycardia
A153	MEDDRA-PT E37 Heart rate increased
A154	MEDDRA-PT-ID E37 10019303
A155	CUI E38 C0030252
A156	UMLS-Preferred-Name E38 Palpitations
A157	MEDDRA-PT E38 Palpitations
A158	MEDDRA-PT-ID E38 10033557
A159	CUI E39 C0033774
A160	UMLS-Preferred-Name E39 Pruritus
A161	MEDDRA-PT E39 Pruritus
A162	MEDDRA-PT-ID E39 10037087
A163	CUI E40 C0015230
A164	UMLS-Preferred-Name E40 Exanthema
A165	MEDDRA-PT E40 Rash
A166	MEDDRA-PT-ID E40 10037844
A167	CUI E41 C0012833
A168	UMLS-Preferred-Name E41 Dizziness
A169	MEDDRA-PT E41 Dizziness
A170	MEDDRA-PT-ID E41 10013573
A171	CUI E42 C0476270
A172	UMLS-Preferred-Name E42 Cardiovascular symptoms
A173	MEDDRA-PT E42 Cardiovascular symptom
A174	MEDDRA-PT-ID E42 10075534
A175	CUI E44 C0006266
A176	UMLS-Preferred-Name E44 Bronchial Spasm
A177	MEDDRA-PT E44 Bronchospasm
A178	MEDDRA-PT-ID E44 10006482
A179	CUI E45 C0740304
A180	UMLS-Preferred-Name E45 COPD exacerbation
A181	MEDDRA-PT E45 Chronic obstructive pulmonary disease
A182	MEDDRA-PT-ID E45 10009033
A183	LLT E45 COPD exacerbation
A184	LLT-ID E45 10010953
A185	CUI E46 C0740304
A186	UMLS-Preferred-Name E46 COPD exacerbation
A187	MEDDRA-PT E46 Chronic obstructive pulmonary disease
A188	MEDDRA-PT-ID E46 10009033
A189	LLT E46 COPD exacerbation
A190	LLT-ID E46 10010953
A191	CUI E47 C0235828
A192	UMLS-Preferred-Name E47 Lack of Efficacy
A193	MEDDRA-PT E47 Drug ineffective
A194	MEDDRA-PT-ID E47 10013709
A195	LLT E47 Efficacy lack of
A196	LLT-ID E47 10048506
A197	CUI E49 C1306577
A198	UMLS-Preferred-Name E49 Death (finding)
A199	MEDDRA-PT E49 Death
A200	MEDDRA-PT-ID E49 10011906
A201	CUI E33 C1306577
A202	UMLS-Preferred-Name E33 Death (finding)
A203	MEDDRA-PT E33 Death
A204	MEDDRA-PT-ID E33 10011906
A205	CUI E52 C0349790
A206	UMLS-Preferred-Name E52 Exacerbation of asthma
A207	MEDDRA-PT E52 Asthma
A208	MEDDRA-PT-ID E52 10003553
A209	LLT E52 Exacerbation of asthma
A210	LLT-ID E52 10015575
